Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Infection Drugs

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Infection Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Infection Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Infection Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
STRAWMAN8
SANDOZ8
NUTRICIA7
TEVA PHARMACEUTICAL INDUSTRIES7
GENERICS UK7
COOKE6
FRESENIUS KABI DEUTSCHLAND5
FRIESLANDCAMPINA NEDERLAND4
HGF4
BOEHRINGER INGELHEIM VETMEDICA4

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
VIIV HEALTHCARE17
GILEAD SCIENCES11
GLAXOSMITHKLINE BIOLOGICALS8
MERCK SHARP & DOHME8
NUTRICIA7
SOCIT DES PRODUITS NESTL7
NESTEC7
INTERVET6
NOVARTIS5
E R SQUIBB & SONS5

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
D YOUNG15
ELKINGTON AND FIFE15
TER MEER STEINMEISTER & PARTNER13
HOFFMANN EITLE8
CARPMAELS & RANSFORD8
NEDERLANDSCH OCTROOIBUREAU7
MEWBURN ELLIS6
HAMM&WITTKOPP PATENTANWALTE PARTMBB6
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB6
FRESENIUS KABI DEUTSCHLAND5

Latest patents opposed in the Infection Drugs industry

Patent challenges are becoming increasingly common in the Infection Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Infection Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Infection Drugs industry

EP4181933Antiviral Pharmaceutical Composition Comprising At Least One Sulphate PolysaccharideMARINOMED BIOTECHJan 17, 2025HAMPTON KNOWLES
EP3565551Methods Of Treating Bacterial InfectionsMELINTA THERAPEUTICSDec 20, 2024GENERICS UK
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 13, 2024ZENTIVA KS
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 12, 2024TEVA PHARMACEUTICAL INDUSTRIES
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 11, 2024NEDERLANDSCH OCTROOIBUREAU
EP3583947Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZERJul 11, 2024SANOFI PASTEUR
EP3432890Product, In Particular Nutritional Supplement, Animal Feed, Foodstuff, Drug, Cosmetic And/Or Animal Feed Supplement For Supplying At Least One Molecule That Bonds To A Vitamin D Receptor, And Method For The Production ThereofBTERApr 12, 2024HERBONIS ANIMAL HEALTH
EP2742945Antimicrobial Locking Solutions Comprising Taurinamide Derivatives And Biologically Acceptable Salts And Acids, With The Addition Of Small Concentrations Of HeparinND PARTNERSMar 28, 2024TAUROPHARM
EP2913327Methylene Blue And Its Medical UsePROVENCEMar 7, 2024AERA
EP3525775Arginine And Its Use As A T Cell ModulatorINSTITUTE FOR RESEARCH IN BIOMEDICINEMar 7, 2024HAMPTON KNOWLES

Top patents facing oppositions in Infection Drugs industry

To stay ahead in the competitive Infection Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Infection Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3494972Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE9
EP3597216Aug 24, 2022Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONS5
EP2899193Mar 14, 2018Crystalline Form Of Abacavir That Is Essentially Free Of SolventESTEVE QUMICA5
EP3127542Aug 22, 2018Antiviral TherapyVIIV HEALTHCARE4
EP3391890Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-CyclodextrinMERCK SHARP & DOHME4
EP4008357Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS4
EP3153526Sep 23, 2020Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE4
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES3
EP3150586Jan 8, 2020Modulators Of Pharmacokinetic Properties Of TherapeuticsGILEAD SCIENCES3
EP2397155Dec 13, 2017Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)PathwayTHE PRESIDENT AND FELLOWS OF HARVARD COLLEGE3